Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®
Posted On Wednesday, April 02, 2025
Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors
Posted On Wednesday, April 02, 2025
FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference
Posted On Wednesday, April 02, 2025
GRI Bio Announces Closing of $5.0 Million Public Offering
Posted On Wednesday, April 02, 2025
Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update
Posted On Wednesday, April 02, 2025
BioCryst to Present at Upcoming Investor Conference
Posted On Wednesday, April 02, 2025
AscellaHealth Releases Q1 2025 Specialty & Rare Pipeline Digest™ Providing Essential Clinical Drug Updates
Posted On Wednesday, April 02, 2025
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
Posted On Wednesday, April 02, 2025
CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
Posted On Wednesday, April 02, 2025
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities
Posted On Wednesday, April 02, 2025
Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
Posted On Wednesday, April 02, 2025
Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab in Phase 2 Multiple Sclerosis Clinical Trial
Posted On Wednesday, April 02, 2025
Opus Genetics to Participate in Upcoming Investor Conference in April
Posted On Wednesday, April 02, 2025
Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program
Posted On Wednesday, April 02, 2025
Ovid Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
Posted On Wednesday, April 02, 2025
Immunocore to present at upcoming investor conferences
Posted On Wednesday, April 02, 2025
Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference
Posted On Wednesday, April 02, 2025
XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference
Posted On Wednesday, April 02, 2025
Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
Posted On Wednesday, April 02, 2025
Grove AI Welcomes Former Novartis, UCB, and Google Executives to Company Advisory Board
Posted On Wednesday, April 02, 2025
Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease
Posted On Wednesday, April 02, 2025
Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
Posted On Wednesday, April 02, 2025
Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient
Posted On Wednesday, April 02, 2025
Moringa: Learn Why These Moringa Powder Supplements Are Transforming Energy, Immunity, and Overall Health
Posted On Wednesday, April 02, 2025
COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order
Posted On Tuesday, April 01, 2025

Print